Business Wire

CA-TALKDESK

4.8.2022 11:32:06 CEST | Business Wire | Press release

Share
SD Worx Chooses Talkdesk Contact Center Solution

Talkdesk®, Inc. , a global contact center leader for customer-obsessed companies, and Microsoft are partnering to deliver a contact center solution for SD Worx . The leading European provider of people solutions selected Talkdesk with Microsoft Teams Connector because it will provide a future-proof platform with enhanced stability to support better customer experiences (CX) through richer agent collaborations.

With headquarters in Belgium, SD Worx has been delivering people solutions across the entire employee lifecycle for more than 75 years. Turning human resources (HR) into a source of value for their more than 80,000 clients across 150 plus countries worldwide, company leaders believe people are at the heart of any business success. SD Worx is driven by a desire to see not only their own global workforce of nearly 7,000 thrive and spark success, but also the five million plus employees they serve each month.

The existing SD Worx contact center operates with separate telephony and case management platforms. Those separate platforms, paired with a combined inbound and outbound volume of more than a million client calls each year, make the process for agents trying to simultaneously gather client insights and field client queries complicated. Talkdesk CX Cloud™, an end-to-end customer experience solution, will provide SD Worx with a modernized, cloud-based contact center platform that can grow with the company.

Additionally, Talkdesk Microsoft Teams Connector™ will enable deeper collaboration between contact center agents and other teams across the organization. Talkdesk for Salesforce™ will further streamline operations and enhance opportunities for personalized engagement across channels. The Talkdesk solution – providing deep integrations with these key platforms – will allow SD Worx agents to more proactively support clients with increased efficiency.

“When we design our contact center flows, I always try to picture myself as one of our clients,” said Yannick Lefever, product owner, SD Worx. “CX comes first here. It’s important to us that the whole customer journey is positive and productive from inquiry to conclusion, and the little details can make or break that experience for all involved. The Talkdesk solution will provide a more seamless experience for SD Worx agents and clients, ensuring that all those details align across platforms and customer touch points.”

“At Microsoft, we strive to exceed customer expectations,” said Mauro Xavier, general manager for partnership solutions, Microsoft. “Partnerships like the one we have with Talkdesk allow us to do exactly that. By integrating best in breed software – Talkdesk CX Cloud and Microsoft Teams – we were able to provide a unique value proposition to SD Worx, enhancing collaboration and enabling a better user experience.”

“For any industry – and especially people solutions – a successful, customer-centric approach to contact center operations hinges on the ability for departments, teams, and individual contact center agents to collaborate seamlessly,” said Tiago Paiva, chief executive officer, Talkdesk. “With the Talkdesk solution, SD Worx is prioritizing the kinds of collaborations across platforms that spark success among contact center agents, and translate to faster issue resolution for clients. We’re proud to partner with Microsoft and SD Worx to deliver exceptional CX for millions of employees every month.”

Additional Resources

Social Networks

About Talkdesk

Talkdesk® is a global cloud contact center leader for customer-obsessed companies. Our automation-first customer experience solutions optimize our customers’ most critical customer service processes. Our speed of innovation, vertical expertise, and global footprint reflect our commitment to ensuring that businesses can deliver better experiences across any industry and through any channel, resulting in higher customer satisfaction and accelerated business outcomes.

Talkdesk is a registered trademark of Talkdesk, Inc. All product and company names are trademarks™ or registered ® trademarks of their respective holders. Use of them does not imply any affiliation or endorsement by them.

About Microsoft

Microsoft (Nasdaq “MSFT” @microsoft) enables digital transformation for the era of an intelligent cloud and an intelligent edge. Its mission is to empower every person and every organization on the planet to achieve more.

About the Talkdesk partner ecosystem:

The Talkdesk global ecosystem represents a diverse network of best-in-class resellers, strategic alliance partners, cloud distributors, and technology vendors focused on providing a better way for organizations to create more meaningful and memorable moments with their customers. These partners support Talkdesk in helping customers across industries and around the world deliver customer experiences that build trust and loyalty.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release

Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye